Stocks / NASDAQ / CAMP4 Therapeutics Corporation

CAMP4 Therapeutics Corporation

Industry: Health Care – Biotechnology

Stock Symbol: CAMP – NASDAQ

Animal Usage: Animal Testing

Our Opinion

CAMP4 Therapeutics Corporation is on the Cruelty Free Investing use of animals list because they conduct pre-clinical studies of their drugs on animals to assess a product’s safety profile.

Supporting Evidence:

The company confirms in the following report that they exploit animals for product testing.

“Furthermore, we tested ASOs upregulating human OTC in a humanized liver mouse model and in cynomolgus monkeys. In both cases, we show that human OTC regRNAtargeting ASOs decrease ammonia and increase urea levels in treated animals.” Read the full document

Company Description

Camp4 Therapeutics Corporation, a clinical-stage biopharmaceutical company, discovers and develops regulatory RNA-based therapeutics to treat a range of genetic diseases. Its lead product candidate is CMP-CPS-001, which is in a Phase 1 clinical trial for the treatment of urea cycle disorders. The company also develops CMP-SYNGAP for the treatment of SYNGAP1-related disorders. Camp4 Therapeutics Corporation was formerly known as Marauder Therapeutics, Inc. and changed its name to Camp4 Therapeutics Corporation in March 2018. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.

Company Website: https://www.camp4tx.com

Contact: sara@milestone-advisorsllc.com